Drug Industry – Page 7

Biotech Industry Prepares for Trump 2.0: Regulatory Changes and M&A Activity Expected

7 months ago talkbio0Tagged biotech industry, Changing, Drug Industry, Health Policy, M&A activity, regulatory environment, Transplant Registry Unified Management Program, United States Food and Drug Administration

Biotech industry, Trump 2.0, FDA changes, M&A activity, regulatory environment, pharmaceutical industry, healthcare policy

Bavarian Nordic Closes San Diego R&D Site, Lays Off 48 Employees

7 months ago talkbio0Tagged Bavarian Nordic, Drug Industry, R&D site closure, San Diego

Bavarian Nordic, San Diego, R&D site closure, layoffs, pharmaceutical industry

From Partnership to Acquisition: The $1.5 Billion Journey of Roche and Poseida Therapeutics

7 months ago talkbio0Tagged Acquisition, allogeneic cell therapy, biotech, CAR-T, Drug Industry, Genetic, genetic medicines, Poseida Therapeutics/ Inc., Roche (company)

Roche Holdings/ Inc., Poseida Therapeutics/ Inc., Allogeneic cell therapy, CAR-T programs, Genetic medicines, Biotech acquisition, Pharmaceutical industry

Eli Lilly Announces $15 Billion Share Buyback Plan and 15% Dividend Increase

7 months ago talkbio0Tagged dividend, Drug Industry, Eli, Eli Lilly, Increase, Market, Share Buyback

Eli Lilly, Share Buyback, Dividend Increase, Pharmaceutical Industry, Stock Market

European Commission Approves Novo Holdings’ $16.5B Acquisition of Catalent

7 months ago talkbio0Tagged Acquisition, Catalent, Commission, Drug Industry, European (ethnic group), Holdings

Novo Holdings, Catalent, European Commission, Acquisition, Pharmaceutical Industry

Amgen Expands in North Carolina with $1 Billion Biomanufacturing Facility

7 months ago talkbio0Tagged amgen, biomanufacturing, Drug Industry, expansion, Facility (object), North Carolina

Amgen, North Carolina, biomanufacturing, facility expansion, pharmaceutical industry

Healthcare M&A and IRA Price Negotiations: Key Trends to Watch Amidst Political Shifts

7 months ago talkbio0Tagged Acquisitions, Drug Industry, drug price, Healthcare M&A, Inflation, Ira (eukaryote), Mediation, Medicare, mergers, Negotiation Program, Prices, trends qualifier

Healthcare M&A, IRA Price Negotiations, Medicare Drug Price Negotiation Program, Inflation Reduction Act, Pharmaceutical Industry Trends, Mergers and Acquisitions Outlook 2024